The device that raised the alarm and saved my life
How heart failure healthtech recommended by NICE helped transform my life.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
How heart failure healthtech recommended by NICE helped transform my life.
Hundreds of people are set to benefit as NICE recommends acalabrutinib for newly diagnosed mantle cell lymphoma and chronic lymphocytic leukaemia.
Artificial intelligence has huge potential to improve health and care, but its use must be safe, effective and fair. In this blog, chief executive Jonathan Benger explains how NICE's new AI delivery plan will support responsible adoption in the NHS, ensuring AI brings real benefits for patients.
Around 6,600 people in England with a serious heart condition will be able to access a new treatment following simultaneous MHRA authorisation and NICE approval today.
Explore support for implementing guidance, making informed decisions and getting involved with NICE.
We've created practical tools, advice and resources to help you put our recommendations into practice, overcome implementation challenges and improve uptake in local services.
We have a library of patient decision aids (PDAs) that help people understand their options, compare treatments and make informed healthcare decisions together with their healthcare professional.
There are lots of ways to get involved with NICE. You can register as a stakeholder, join a committee or working group, attend open meetings, or even work with us directly to help shape our guidance
Modular updates focus on reviewing specific methods or processes used to develop NICE guidance. Submit your ideas and suggestions from Monday 15 June to Sunday 16 August.
Our annual report and accounts covering April 2025 to March 2026 (PDF) highlight our key achievements. Find out how we’re delivering against the 10 Year Health plan, and how we’re becoming more relevant, timely, impactful and usable.